Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Study of Fluoxetine in Children and Adolescents With Autism
This study has been completed.
Study NCT00004486   Information provided by FDA Office of Orphan Products Development
First Received: October 18, 1999   Last Updated: December 7, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autism
Additional conditions recognized in this trial
Autistic Disorder
More general conditions related to this trial
Child Development Disorders, Pervasive
Mental Disorders
Mental Disorders Diagnosed in Childhood
Interventions listed in this trial
fluoxetine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
FDA Office of Orphan Products Development
Mount Sinai School of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services